Cargando…
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor
Background: COVID-19 clinical features include a hypercoagulable state that resembles the antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of antiphospholipid antibodies (aPL). The relationship between aPL-presence and the appearance of thrombi as well as the trans...
Autores principales: | Gil-Etayo, Francisco Javier, Garcinuño, Sara, Lalueza, Antonio, Díaz-Simón, Raquel, García-Reyne, Ana, Pleguezuelo, Daniel Enrique, Cabrera-Marante, Oscar, Rodriguez-Frias, Edgard Alfonso, Perez-Rivilla, Alfredo, Serrano, Manuel, Serrano, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389622/ https://www.ncbi.nlm.nih.gov/pubmed/34440103 http://dx.doi.org/10.3390/biomedicines9080899 |
Ejemplares similares
-
Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution
por: Garcinuño, Sara, et al.
Publicado: (2022) -
Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021) -
Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021) -
An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2022) -
The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome
por: Cabrera-Marante, Oscar, et al.
Publicado: (2020)